Toxicity and outcomes of melanoma brain metastases treated with stereotactic radiosurgery: the risk of subsequent symptomatic intralesional hemorrhage exceeds that of radiation necrosis
ConclusionThe risk of g2 + IH exceeds that of g2 + RN in MBM patients undergoing SRS, with or without IO. IH should be considered a critical adverse event following MBM treatments.Graphical Abstract
Source: Journal of Neuro-Oncology - Category: Cancer & Oncology Source Type: research
More News: Brain | Cancer & Oncology | Chemotherapy | Hemorrhagic Stroke | Immunotherapy | Melanoma | Neurology | Neurosurgery | Skin Cancer | Toxicology | Yervoy